Glycosaminoglycan mixtures
AssigneeAgency for Science, Technology and Research
InventorsSimon Cool, Victor Nurcombe
Life of this patent
Estimating the term…
Abstract
The present invention relates to osteoblast derived glycosaminoglycan mixtures and to their use in one or more of: inhibition of osteoclastogenesis, enhancement of proliferation of osteoblasts, and/or the treatment or prevention of bone fracture or bone deterioration.
Claims17
A glycosaminoglycan mixture obtained from mammalian osteoblasts for use in the inhibition of osteoclastogenesis in a mammal.
A glycosaminoglycan mixture obtained from mammalian osteoblasts for use in the treatment and/or prevention of bone fracture or bone deterioration in a mammal.
A glycosaminoglycan mixture obtained from mammalian osteoblasts for use in enhancing proliferation of osteoblasts in a mammal.
Use of a glycosaminoglycan mixture obtained from mammalian osteoblasts in the manufacture of a medicament for the inhibition of osteoclastogenesis in a mammal.
Use of a glycosaminoglycan mixture obtained from mammalian osteoblasts in the manufacture of a medicament for the treatment and/or prevention of bone fracture or bone deterioration in a mammal.
Use of a glycosaminoglycan mixture obtained from mammalian osteoblasts in the manufacture of a medicament for enhancing proliferation of osteoblasts in a mammal.
A method of inhibiting osteoclastogenesis in a mammal in need of such treatment, the method comprising administering a glycosaminoglycan mixture obtained from mammalian osteoblasts to the mammal.
A method of treating and/or preventing bone fracture or bone deterioration in a mammal in need of such treatment, the method comprising administering a glycosaminoglycan mixture obtained from mammalian osteoblasts to the mammal.
A method of enhancing proliferation of osteoblasts in a mammal in need of such treatment, the method comprising administering a glycosaminoglycan mixture obtained from mammalian osteoblasts to the mammal.
A method of inhibiting osteoclastogenesis, the method comprising administering a glycosaminoglycan mixture obtained from mammalian osteoblasts to osteoclasts or osteoblasts, in vitro or in vivo.
A method of enhancing proliferation of osteoblasts, the method comprising administering a glycosaminoglycan mixture obtained from mammalian osteoblasts to osteoblasts in vitro or in vivo.
A pharmaceutical composition or medicament, the pharmaceutical composition or medicament comprising a glycosaminoglycan mixture obtained from mammalian osteoblasts.
An isolated glycosaminoglycan mixture obtained from mammalian osteoblasts
Dependencies are inferred from the claim text.